CytomX Therapeutics (CTMX) Other Non-Current Assets (2016 - 2025)
Historic Other Non-Current Assets for CytomX Therapeutics (CTMX) over the last 12 years, with Q3 2025 value amounting to $1.0 million.
- CytomX Therapeutics' Other Non-Current Assets rose 9.74% to $1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 9.74%. This contributed to the annual value of $1.0 million for FY2024, which is 1199.56% up from last year.
- Per CytomX Therapeutics' latest filing, its Other Non-Current Assets stood at $1.0 million for Q3 2025, which was up 9.74% from $1.0 million recorded in Q2 2025.
- In the past 5 years, CytomX Therapeutics' Other Non-Current Assets registered a high of $1.0 million during Q1 2025, and its lowest value of $917000.0 during Q1 2021.
- Its 5-year average for Other Non-Current Assets is $946105.3, with a median of $917000.0 in 2021.
- Per our database at Business Quant, CytomX Therapeutics' Other Non-Current Assets plummeted by 5778.08% in 2021 and then surged by 1210.47% in 2025.
- CytomX Therapeutics' Other Non-Current Assets (Quarter) stood at $917000.0 in 2021, then changed by 0.0% to $917000.0 in 2022, then changed by 0.0% to $917000.0 in 2023, then increased by 12.0% to $1.0 million in 2024, then rose by 0.1% to $1.0 million in 2025.
- Its last three reported values are $1.0 million in Q3 2025, $1.0 million for Q2 2025, and $1.0 million during Q1 2025.